1. Home
  2. GNTY vs CTMX Comparison

GNTY vs CTMX Comparison

Compare GNTY & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTY
  • CTMX
  • Stock Information
  • Founded
  • GNTY 1913
  • CTMX 2008
  • Country
  • GNTY United States
  • CTMX United States
  • Employees
  • GNTY N/A
  • CTMX N/A
  • Industry
  • GNTY Major Banks
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNTY Finance
  • CTMX Health Care
  • Exchange
  • GNTY Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • GNTY 520.5M
  • CTMX 376.5M
  • IPO Year
  • GNTY 2017
  • CTMX 2015
  • Fundamental
  • Price
  • GNTY $44.76
  • CTMX $2.32
  • Analyst Decision
  • GNTY Buy
  • CTMX Strong Buy
  • Analyst Count
  • GNTY 2
  • CTMX 2
  • Target Price
  • GNTY $44.50
  • CTMX $5.00
  • AVG Volume (30 Days)
  • GNTY 58.0K
  • CTMX 1.4M
  • Earning Date
  • GNTY 07-21-2025
  • CTMX 08-11-2025
  • Dividend Yield
  • GNTY 2.20%
  • CTMX N/A
  • EPS Growth
  • GNTY 37.68
  • CTMX 128.27
  • EPS
  • GNTY 3.13
  • CTMX 0.49
  • Revenue
  • GNTY $127,325,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • GNTY $10.99
  • CTMX N/A
  • Revenue Next Year
  • GNTY $4.83
  • CTMX N/A
  • P/E Ratio
  • GNTY $14.53
  • CTMX $4.77
  • Revenue Growth
  • GNTY 10.12
  • CTMX 23.81
  • 52 Week Low
  • GNTY $29.65
  • CTMX $0.40
  • 52 Week High
  • GNTY $47.20
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • GNTY 50.66
  • CTMX 47.76
  • Support Level
  • GNTY $44.02
  • CTMX $2.18
  • Resistance Level
  • GNTY $46.55
  • CTMX $2.47
  • Average True Range (ATR)
  • GNTY 1.12
  • CTMX 0.12
  • MACD
  • GNTY -0.21
  • CTMX -0.02
  • Stochastic Oscillator
  • GNTY 30.53
  • CTMX 31.11

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: